Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Recovery of Adrenal Function after Pituitary Surgery in Patients with Cushing Disease: Persistent Remission or Recurrence?

Serban AL, Sala E, Carosi G, Del Sindaco G, Giavoli C, Locatelli M, Arosio M, Mantovani G, Ferrante E.

Neuroendocrinology. 2019;108(3):211-218. doi: 10.1159/000496846. Epub 2019 Jan 13.

PMID:
30636245
2.

Piezoelectrically Tuned Multimode Cavity Search for Axion Dark Matter.

Boutan C, Jones M, LaRoque BH, Oblath NS, Cervantes R, Du N, Force N, Kimes S, Ottens R, Rosenberg LJ, Rybka G, Yang J, Carosi G, Woollett N, Bowring D, Chou AS, Khatiwada R, Sonnenschein A, Wester W, Bradley R, Daw EJ, Agrawal A, Dixit AV, Clarke J, O'Kelley SR, Crisosto N, Gleason JR, Jois S, Sikivie P, Stern I, Sullivan NS, Tanner DB, Harrington PM, Lentz E; ADMX Collaboration.

Phys Rev Lett. 2018 Dec 28;121(26):261302. doi: 10.1103/PhysRevLett.121.261302.

PMID:
30636160
3.

Natural history of Rathke's cleft cysts: A retrospective analysis of a two centres experience.

Sala E, Moore JM, Amorin A, Carosi G, Martinez H Jr, Harsh GR, Arosio M, Mantovani G, Katznelson L.

Clin Endocrinol (Oxf). 2018 May 21. doi: 10.1111/cen.13744. [Epub ahead of print]

PMID:
29781512
4.

Search for Invisible Axion Dark Matter with the Axion Dark Matter Experiment.

Du N, Force N, Khatiwada R, Lentz E, Ottens R, Rosenberg LJ, Rybka G, Carosi G, Woollett N, Bowring D, Chou AS, Sonnenschein A, Wester W, Boutan C, Oblath NS, Bradley R, Daw EJ, Dixit AV, Clarke J, O'Kelley SR, Crisosto N, Gleason JR, Jois S, Sikivie P, Stern I, Sullivan NS, Tanner DB, Hilton GC; ADMX Collaboration.

Phys Rev Lett. 2018 Apr 13;120(15):151301. doi: 10.1103/PhysRevLett.120.151301.

5.

First Results from a Microwave Cavity Axion Search at 24  μeV.

Brubaker BM, Zhong L, Gurevich YV, Cahn SB, Lamoreaux SK, Simanovskaia M, Root JR, Lewis SM, Al Kenany S, Backes KM, Urdinaran I, Rapidis NM, Shokair TM, van Bibber KA, Palken DA, Malnou M, Kindel WF, Anil MA, Lehnert KW, Carosi G.

Phys Rev Lett. 2017 Feb 10;118(6):061302. doi: 10.1103/PhysRevLett.118.061302. Epub 2017 Feb 9.

PMID:
28234529
6.

Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
.

Cattaneo D, Andreoni M, Carosi G, Cauda R, Lazzarin A, Rizzardini G.

Int J Clin Pharmacol Ther. 2017 May;55(5):381-393. doi: 10.5414/CP202775. Review.

PMID:
28211784
7.

Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study).

Cerini C, Casari S, Donato F, Porteri E, Rodella A, Terlenghi L, Compostella S, Apostoli A, Brianese N, Urbinati L, Salvi A, Rossini A, Agabiti Rosei E, Caruso A, Carosi G, Castelli F.

Infect Dis (Lond). 2016 Nov-Dec;48(11-12):838-43. doi: 10.3109/23744235.2016.1169551. Epub 2016 Aug 11.

PMID:
27622515
8.

Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.

Sala E, Bellaviti Buttoni P, Malchiodi E, Verrua E, Carosi G, Profka E, Rodari G, Filopanti M, Ferrante E, Spada A, Mantovani G.

J Endocrinol Invest. 2016 Dec;39(12):1377-1382. Epub 2016 May 31.

PMID:
27245604
9.

Cavity design for high-frequency axion dark matter detectors.

Stern I, Chisholm AA, Hoskins J, Sikivie P, Sullivan NS, Tanner DB, Carosi G, van Bibber K.

Rev Sci Instrum. 2015 Dec;86(12):123305. doi: 10.1063/1.4938164.

PMID:
26724020
10.

Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort).

Torti C, Raffetti E, Donato F, Castelli F, Maggiolo F, Angarano G, Mazzotta F, Gori A, Sighinolfi L, Pan A, Cauda R, Scalzini A, Quiros-Roldan E, Nasta P, Gregis G, Benatti S, Digiambenedetto S, Ladisa N, Giralda M, Saracino A, Castelnuovo F, Di Pietro M, Lo Caputo S, Lapadula G, Costarelli S, Lorenzotti S, Mazzini N, Paraninfo G, Casari S, Focà E, Pezzoli C, Fabbiani M, Monno L, Pierotti P, Ble C, Leone S, Postorino MC, Fornabaio C, Zacchi F, Zoncada A, Carosi G.

Int J Epidemiol. 2017 Apr 1;46(2):e12. doi: 10.1093/ije/dyv192. No abstract available.

PMID:
26445966
11.

The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study.

Raffetti E, Donato F, Castelli F, Maggiolo F, Carosi G, Quiros-Roldan E.

Infect Agent Cancer. 2015 Oct 5;10:34. doi: 10.1186/s13027-015-0032-y. eCollection 2015.

12.

Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas: Focus on the Prevalence of Isolated Central Hypoadrenalism.

Carosi G, Malchiodi E, Ferrante E, Sala E, Verrua E, Profka E, Giavoli C, Filopanti M, Beck-Peccoz P, Spada A, Mantovani G.

Neuroendocrinology. 2015;102(4):267-273. Epub 2015 Apr 29.

PMID:
25924873
13.

Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy.

Cure S, Guerra I, Cammà C, Craxì A, Carosi G.

J Med Econ. 2015;18(9):678-90. doi: 10.3111/13696998.2015.1040024. Epub 2015 Jun 5.

PMID:
25891129
14.

Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.

Nasta P, Maida I, Cattelan AM, Pontali E, Angeli E, Giralda M, Verucchi G, Caputo A, Iannacone C, Puoti M, Carosi G.

J Womens Health (Larchmt). 2015 Feb;24(2):159-64. doi: 10.1089/jwh.2014.4796. Epub 2015 Feb 3.

PMID:
25682817
15.

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G.

New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1.

16.

High statistics measurement of the positron fraction in primary cosmic rays of 0.5-500 GeV with the alpha magnetic spectrometer on the international space station.

Accardo L, Aguilar M, Aisa D, Alpat B, Alvino A, Ambrosi G, Andeen K, Arruda L, Attig N, Azzarello P, Bachlechner A, Barao F, Barrau A, Barrin L, Bartoloni A, Basara L, Battarbee M, Battiston R, Bazo J, Becker U, Behlmann M, Beischer B, Berdugo J, Bertucci B, Bigongiari G, Bindi V, Bizzaglia S, Bizzarri M, Boella G, de Boer W, Bollweg K, Bonnivard V, Borgia B, Borsini S, Boschini MJ, Bourquin M, Burger J, Cadoux F, Cai XD, Capell M, Caroff S, Carosi G, Casaus J, Cascioli V, Castellini G, Cernuda I, Cerreta D, Cervelli F, Chae MJ, Chang YH, Chen AI, Chen H, Cheng GM, Chen HS, Cheng L, Chikanian A, Chou HY, Choumilov E, Choutko V, Chung CH, Cindolo F, Clark C, Clavero R, Coignet G, Consolandi C, Contin A, Corti C, Coste B, Cui Z, Dai M, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Di Masso L, Dimiccoli F, Díaz C, von Doetinchem P, Du WJ, Duranti M, D'Urso D, Eline A, Eppling FJ, Eronen T, Fan YY, Farnesini L, Feng J, Fiandrini E, Fiasson A, Finch E, Fisher P, Galaktionov Y, Gallucci G, García B, García-López R, Gast H, Gebauer I, Gervasi M, Ghelfi A, Gillard W, Giovacchini F, Goglov P, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Guandalini C, Guerri I, Guo KH, Haas D, Habiby M, Haino S, Han KC, He ZH, Heil M, Henning R, Hoffman J, Hsieh TH, Huang ZC, Huh C, Incagli M, Ionica M, Jang WY, Jinchi H, Kanishev K, Kim GN, Kim KS, Kirn T, Kossakowski R, Kounina O, Kounine A, Koutsenko V, Krafczyk MS, Kunz S, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Leluc C, Levi G, Li HL, Li JQ, Li Q, Li Q, Li TX, Li W, Li Y, Li ZH, Li ZY, Lim S, Lin CH, Lipari P, Lippert T, Liu D, Liu H, Lolli M, Lomtadze T, Lu MJ, Lu YS, Luebelsmeyer K, Luo F, Luo JZ, Lv SS, Majka R, Malinin A, Mañá C, Marín J, Martin T, Martínez G, Masi N, Massera F, Maurin D, Menchaca-Rocha A, Meng Q, Mo DC, Monreal B, Morescalchi L, Mott P, Müller M, Ni JQ, Nikonov N, Nozzoli F, Nunes P, Obermeier A, Oliva A, Orcinha M, Palmonari F, Palomares C, Paniccia M, Papi A, Pauluzzi M, Pedreschi E, Pensotti S, Pereira R, Pilastrini R, Pilo F, Piluso A, Pizzolotto C, Plyaskin V, Pohl M, Poireau V, Postaci E, Putze A, Quadrani L, Qi XM, Rancoita PG, Rapin D, Ricol JS, Rodríguez I, Rosier-Lees S, Rossi L, Rozhkov A, Rozza D, Rybka G, Sagdeev R, Sandweiss J, Saouter P, Sbarra C, Schael S, Schmidt SM, Schuckardt D, Schulz von Dratzig A, Schwering G, Scolieri G, Seo ES, Shan BS, Shan YH, Shi JY, Shi XY, Shi YM, Siedenburg T, Son D, Spada F, Spinella F, Sun W, Sun WH, Tacconi M, Tang CP, Tang XW, Tang ZC, Tao L, Tescaro D, Ting SC, Ting SM, Tomassetti N, Torsti J, Türkoğlu C, Urban T, Vagelli V, Valente E, Vannini C, Valtonen E, Vaurynovich S, Vecchi M, Velasco M, Vialle JP, Vitale V, Volpini G, Wang LQ, Wang QL, Wang RS, Wang X, Wang ZX, Weng ZL, Whitman K, Wienkenhöver J, Wu H, Wu KY, Xia X, Xie M, Xie S, Xiong RQ, Xin GM, Xu NS, Xu W, Yan Q, Yang J, Yang M, Ye QH, Yi H, Yu YJ, Yu ZQ, Zeissler S, Zhang JH, Zhang MT, Zhang XB, Zhang Z, Zheng ZM, Zhou F, Zhuang HL, Zhukov V, Zichichi A, Zimmermann N, Zuccon P, Zurbach C; AMS Collaboration.

Phys Rev Lett. 2014 Sep 19;113(12):121101. Epub 2014 Sep 18.

PMID:
25279616
17.

Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study.

Zoulim F, Carosi G, Greenbloom S, Mazur W, Nguyen T, Jeffers L, Brunetto M, Yu S, Llamoso C.

J Hepatol. 2015 Jan;62(1):56-63. doi: 10.1016/j.jhep.2014.08.031. Epub 2014 Aug 28.

PMID:
25176615
18.

Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT).

Bruno R, Carosi G, Coppola N, Gaeta GB, Puoti M, Santantonio T, Taliani G, Armignacco O, Sagnelli E, Andreoni M, Angarano G, Di Perri G, D'Offizi G, Galli M, Rizzardini G; Italian Society for the Study of Infectious and Tropical Diseases.

Infection. 2014 Oct;42(5):811-5. doi: 10.1007/s15010-014-0642-0. Epub 2014 Jul 6. Review.

PMID:
24997980
19.

Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency.

Rosina F, Tosti ME, Borghesio E, Masocco M, Mele A, Coppola C, Milella M, Borgia G, Andreone P, Koch M, Zignego AL, Romano M, Carrara M, Almasio PL, Azzola E, Nardone G, Benedetti A, Carosi G, Mazzotta F, Sagnelli E, Rizzetto M; AIFA Study Group; Italian Association for the Study of the Liver (AISF); Italian Society for Infectious and Tropical Diseases (SIMIT); Italian Association of Hospital Gastroenterologists (AIGO); Italian Society of Gastroenterology (SIGE); Italian Association for the Study of the Liver AISF; Italian Society for Infectious and Tropical Diseases SIMIT; Italian Association of Hospital Gastroenterologists AIGO; Italian Society of Gastroenterology SIGE.

Dig Liver Dis. 2014 Sep;46(9):826-32. doi: 10.1016/j.dld.2014.05.014. Epub 2014 Jun 28.

PMID:
24986781
20.

OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients.

Carosi G, Bruno R, Cariti G, Nasta P, Gulminetti R, Galli M, Angarano G, Verucchi G, Pontali E, Capetti A, Raise E, Ravasio V, Maida I, Iannacone C, Caputo A, Puoti M.

Antivir Ther. 2014;19(8):735-45. doi: 10.3851/IMP2757. Epub 2014 Feb 28.

PMID:
24583976
21.

Epidemiological and clinical characteristics and behaviours of individuals with newly diagnosed HIV infection: a multicentre study in north Italy.

Casari S, Suligoi B, Camoni L, Pavan A, Macchi L, Capelli M, Paraninfo G, Compostella S, Castelli F, Carosi G, Donato F; NU.DI.H. Study Group.

J Prev Med Hyg. 2012 Dec;53(4):190-4.

PMID:
23469586
22.

Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.

Fasano M, Saracino A, Carosi G, Mazzotta F, Marino N, Sagnelli E, Gaeta GB, Angarano G, Verucchi G, Bellissima P, Angeletti C, Santantonio T.

Infection. 2013 Feb;41(1):53-9. doi: 10.1007/s15010-012-0384-9. Epub 2012 Dec 21.

PMID:
23264094
23.

Towards HCV extinction with modern HCV treatment? "Yes we can!".

Torti C, Focà A, Carosi G.

BMC Infect Dis. 2012;12 Suppl 2:S1. doi: 10.1186/1471-2334-12-S2-S1. Epub 2012 Nov 12. No abstract available.

24.

Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy.

Antonucci G, Mazzotta F, Puoti M, Angeletti C, Girardi E, Santantonio T, Ambu S, Gaeta GB, Colucci M, Angarano G, Marino N, Rinaldi R, Bellissima P, Armignacco O, Carosi G, Sagnelli E; Coorte Epatiti B SIMIT (COESI-B) Group.

J Viral Hepat. 2012 Dec;19(12):881-9. doi: 10.1111/j.1365-2893.2012.01615.x. Epub 2012 May 10.

PMID:
23121367
25.

Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke.

Barsic B, Dickerman S, Krajinovic V, Pappas P, Altclas J, Carosi G, Casabé JH, Chu VH, Delahaye F, Edathodu J, Fortes CQ, Olaison L, Pangercic A, Patel M, Rudez I, Tamin SS, Vincelj J, Bayer AS, Wang A; International Collaboration on Endocarditis–Prospective Cohort Study Investigators.

Clin Infect Dis. 2013 Jan;56(2):209-17. doi: 10.1093/cid/cis878. Epub 2012 Oct 16.

PMID:
23074311
26.

Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.

Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, Barzaghi N, Falcone M, Chinello P, Pasticci MB, Grossi P, Utili R, Viale P, Rizzi M, Suter F.

Infection. 2012 Oct;40(5):527-35. doi: 10.1007/s15010-012-0285-y. Epub 2012 Jun 19.

PMID:
22711599
27.

Malaria and hiv in adults: when the parasite runs into the virus.

Focà E, Odolini S, Brianese N, Carosi G.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012032. doi: 10.4084/MJHID.2012.032. Epub 2012 May 7.

28.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Armignacco O, Carosi G, Cinque P, d'Arminio Monforte A, Di Perri G, Ensoli B, Floridia M, Galli M, Mastroianni C, Matteelli A, Mazzotta F, Moroni M, Pal G, Puoti M, Puro V, Rizzardini G, Sagnelli E, Vella S, Vullo V, Lazzarin A; Italian HIV Guidelines Working Group.

New Microbiol. 2012 Apr;35(2):113-59. Epub 2012 Mar 31. No abstract available.

29.

Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

Lok AS, Trinh H, Carosi G, Akarca US, Gadano A, Habersetzer F, Sievert W, Wong D, Lovegren M, Cohen D, Llamoso C.

Gastroenterology. 2012 Sep;143(3):619-628.e1. doi: 10.1053/j.gastro.2012.05.037. Epub 2012 May 27.

PMID:
22643350
30.

Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillance.

Fogli M, Torti C, Malacarne F, Fiorentini S, Albani M, Izzo I, Giagulli C, Maggi F, Carosi G, Caruso A.

Clin Dev Immunol. 2012;2012:829584. doi: 10.1155/2012/829584. Epub 2012 Mar 5.

31.

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.

Serfaty L, Forns X, Goeser T, Ferenci P, Nevens F, Carosi G, Drenth JP, Lonjon-Domanec I, DeMasi R, Picchio G, Beumont M, Marcellin P.

Gut. 2012 Oct;61(10):1473-80. doi: 10.1136/gutjnl-2011-300749. Epub 2012 Mar 2.

PMID:
22387529
32.

Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.

Svicher V, Alteri C, Montano M, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Callegaro AP, Capobianchi MR, Carosi G, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Pietro M, Di Santo F, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori C, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Manca G, Gargiulo F, Martinelli C, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Narciso P, Nozza S, Paolucci S, Pal G, Parisi S, Parruti G, Pignataro AR, Pollicita M, Quirino T, Re MC, Rizzardini G, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Vecchi L, Viscoli C, Vullo V, Zazzi M, Lazzarini A, Perno CF; DIVA group.

New Microbiol. 2012 Jan;35(1):17-25. Epub 2012 Jan 10.

33.

Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients.

Marchetti G, Nasta P, Bai F, Gatti F, Bellistrì GM, Tincati C, Borghi F, Carosi G, Puoti M, Monforte Ad.

PLoS One. 2012;7(2):e32028. doi: 10.1371/journal.pone.0032028. Epub 2012 Feb 21.

34.

High prevalence of radiological vertebral fractures in HIV-infected males.

Torti C, Mazziotti G, Soldini PA, Focà E, Maroldi R, Gotti D, Carosi G, Giustina A.

Endocrine. 2012 Jun;41(3):512-7. doi: 10.1007/s12020-011-9586-7. Epub 2011 Dec 25.

PMID:
22198528
35.

Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort.

Vescini F, Cozzi-Lepri A, Borderi M, Re MC, Maggiolo F, De Luca A, Cassola G, Vullo V, Carosi G, Antinori A, Tozzi V, Monforte AD; Icona Foundation Study Group.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):163-72. doi: 10.1097/QAI.0b013e31822e57e9.

PMID:
21826011
36.

Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections.

Foster GR, Hézode C, Bronowicki JP, Carosi G, Weiland O, Verlinden L, van Heeswijk R, van Baelen B, Picchio G, Beumont M.

Gastroenterology. 2011 Sep;141(3):881-889.e1. doi: 10.1053/j.gastro.2011.05.046. Epub 2011 May 31.

PMID:
21699786
37.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.

Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Carosi G, Cinque P, d'Arminio Monforte A, Di Perri G, Ensoli B, Ferrazzi E, Galli M, Mastroianni C, Matteelli A, Mazzotta F, Moroni M, Palù G, Puoti M, Puro V, Rizzardini G, Sagnelli E, Suter F, Vella S, Lazzarin A; Italian HIV Guidelines Working Group.

New Microbiol. 2011 Apr;34(2):109-46. Epub 2011 Apr 30. No abstract available.

38.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C.

Clin Infect Dis. 2011 May;52(9):1164-73. doi: 10.1093/cid/cir071.

PMID:
21467023
39.

Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy).

Izzo I, Forleo MA, Casari S, Quiros-Roldan E, Magoni M, Carosi G, Torti C.

BMC Public Health. 2011 Feb 21;11:124. doi: 10.1186/1471-2458-11-124.

40.

Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop.

Carosi G, Rizzetto M, Alberti A, Cariti G, Colombo M, Craxì A, Filice G, Levrero M, Mazzotta F, Pastore G, Piccinino F, Prati D, Raimondo G, Sagnelli E, Toti M, Brunetto M, Bruno R, Di Marco V, Ferrari C, Gaeta GB, Lampertico P, Marzano A, Pollicino T, Puoti M, Santantonio T, Smedile A.

Dig Liver Dis. 2011 Apr;43(4):259-65. doi: 10.1016/j.dld.2010.10.014. Epub 2011 Jan 26. Review.

PMID:
21276760
41.

Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI.

Torti C, d'Arminio-Monforte A, Pozniak AL, Lapadula G, Cologni G, Antinori A, De Luca A, Mussini C, Castagna A, Cicconi P, Minoli L, Costantini A, Carosi G, Liang H, Cesana BM; MASTER, Chelsea & Westminster, ICONA, Modena and S. Raffaele HIV Cohorts.

BMC Infect Dis. 2011 Jan 25;11:23. doi: 10.1186/1471-2334-11-23.

42.

Search for hidden sector photons with the ADMX detector.

Wagner A, Rybka G, Hotz M, Rosenberg LJ, Asztalos SJ, Carosi G, Hagmann C, Kinion D, van Bibber K, Hoskins J, Martin C, Sikivie P, Tanner DB, Bradley R, Clarke J.

Phys Rev Lett. 2010 Oct 22;105(17):171801. Epub 2010 Oct 19.

PMID:
21231034
43.

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.

Ensoli B, Bellino S, Tripiciano A, Longo O, Francavilla V, Marcotullio S, Cafaro A, Picconi O, Paniccia G, Scoglio A, Arancio A, Ariola C, Ruiz Alvarez MJ, Campagna M, Scaramuzzi D, Iori C, Esposito R, Mussini C, Ghinelli F, Sighinolfi L, Palamara G, Latini A, Angarano G, Ladisa N, Soscia F, Mercurio VS, Lazzarin A, Tambussi G, Visintini R, Mazzotta F, Di Pietro M, Galli M, Rusconi S, Carosi G, Torti C, Di Perri G, Bonora S, Ensoli F, Garaci E.

PLoS One. 2010 Nov 11;5(11):e13540. doi: 10.1371/journal.pone.0013540.

44.

Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen.

Ghosn J, Carosi G, Moreno S, Pokrovsky V, Lazzarin A, Pialoux G, Sanz-Moreno J, Balogh A, Vandeloise E, Biguenet S, Leleu G, Delfraissy JF.

Antivir Ther. 2010;15(7):993-1002. doi: 10.3851/IMP1666.

PMID:
21041914
45.

Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis C.

Marcellin P, Forns X, Goeser T, Ferenci P, Nevens F, Carosi G, Drenth JP, Serfaty L, De Backer K, Van Heeswijk R, Luo D, Picchio G, Beumont M.

Gastroenterology. 2011 Feb;140(2):459-468.e1; quiz e14. doi: 10.1053/j.gastro.2010.10.046. Epub 2010 Oct 26.

PMID:
21034744
46.

Search for chameleon scalar fields with the axion dark matter experiment.

Rybka G, Hotz M, Rosenberg LJ, Asztalos SJ, Carosi G, Hagmann C, Kinion D, van Bibber K, Hoskins J, Martin C, Sikivie P, Tanner DB, Bradley R, Clarke J.

Phys Rev Lett. 2010 Jul 30;105(5):051801. Epub 2010 Jul 26.

PMID:
20867906
47.

Consensus document on controversial issues for the treatment of hospital-associated pneumonia.

Franzetti F, Antonelli M, Bassetti M, Blasi F, Langer M, Scaglione F, Nicastri E, Lauria FN, Carosi G, Moroni M, Ippolito G; GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Hospital-Associated Pneumonia.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S55-65. doi: 10.1016/j.ijid.2010.05.008. Epub 2010 Sep 22.

48.

The impact of gender and anchor drugs on TDF renal toxicity.

Quiros-Roldan E, Amadasi S, Paraninfo G, Izzo I, Allegri R, Motta D, Gatti F, Cristini G, Carosi G, Mendeni M, Torti C.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):e11-2. doi: 10.1097/QAI.0b013e3181ef7930. No abstract available.

PMID:
20859083
49.

Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections.

Pan A, Cauda R, Concia E, Esposito S, Sganga G, Stefani S, Nicastri E, Lauria FN, Carosi G, Moroni M, Ippolito G; GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Complicated Skin and Skin-Structure Infections.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S39-53. doi: 10.1016/j.ijid.2010.05.007. Epub 2010 Sep 20.

50.

Gruppo Italiano di Studio sulle Infezioni Gravi - GISIG 3: controversial issues of severe bacterial infections due to multidrug-resistant Gram-positive bacteria: introduction by the National Coordinators.

Ippolito G, Moroni M, Carosi G.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S1. doi: 10.1016/j.ijid.2010.05.001. Epub 2010 Sep 20. No abstract available.

Supplemental Content

Loading ...
Support Center